Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
about
The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferationBioidentical hormones for menopausal hormone therapy: variation on a themeIdentification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal womenCurrent perspectives between metabolic syndrome and cancerPrevention of breast cancer in postmenopausal women: approaches to estimating and reducing riskRisk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study.Androgen Receptor as a Potential Target for Treatment of Breast Cancer.Low salivary testosterone levels in patients with breast cancer.Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor statusOn Estimation of Partially Linear Transformation Models.Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.The association of reproductive and lifestyle factors with a score of multiple endogenous hormones.Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.Reliability of serum assays of iron status in postmenopausal women.Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.Reproducibility of serum cytokines and growth factorsCirculating estrogen metabolites and risk for breast cancer in premenopausal womenA Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal womenSex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancersPhysical Activity in the Prevention and Therapy of Breast Cancer.Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.Dietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal womenCirculating sex steroids and breast cancer risk in premenopausal women.The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal womenSerum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinomaGenetic variants in hypothalamic-pituitary-adrenal axis genes and breast cancer risk in Caucasians and African AmericansSex hormone binding globulin in breast cancer.Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase.Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study.Premenopausal serum androgens and breast cancer risk: a nested case-control study.Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women.Does estrogen play a role in response to adjuvant bone-targeted therapies?Circulating enterolactone and risk of breast cancer: a prospective study in New YorkPostmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.
P2860
Q21134778-03850D97-717A-4379-837B-D5CDFDB79CD9Q24643351-84B5C6CC-355E-4145-B5A9-5BD259D0142FQ24653491-5B3E2723-F3F0-41B0-9DAB-941733832E60Q26749299-0C2BDAB8-F660-4D07-A5B2-10F1A85CE795Q28390064-A033BDCB-D7DE-4D90-AEE1-9C25F220FFBFQ31161296-D6893FBE-5C86-4FE0-9564-A525A50E5ACEQ33625672-1A1ECC86-D9BA-40B1-AEB5-AF2BF9CAA42FQ33715095-83DECF63-3DE9-40B9-90D1-8ABB8A4F4452Q33847977-69B0CB17-0961-4C02-8D1B-B3E8A7B81BF4Q33872842-8336247B-E34B-400A-8296-65F27DBBDE14Q33891825-43BFA175-68E6-417F-A113-A5E430D26B1CQ34043711-D17156DB-E79D-46AD-90C5-C865A2AD3B48Q34087740-87A07A54-6D93-4A7F-87A7-BF2C7CEB3C5FQ34198265-E158BC4C-1A9F-4E03-B98E-36DF90354339Q34204763-3E5A7554-8EF8-460A-A1A2-5DFD08437927Q34225990-C2C39B60-249C-469E-A360-F5C51F7B7FDAQ34245810-B80AD314-44FF-415F-BB29-3B3AD38C574EQ34295620-C25A08F5-8E30-4AFA-8615-49F38D2401D9Q34305127-CA03307C-1C52-4557-BBF9-A0A29743FC11Q34399685-DCB2DA14-1C94-4884-80DA-15F7ADD62175Q34550256-CC3DDB82-F237-456C-8CA3-9342C521B506Q34642072-5C056AE1-249E-4BA8-819F-0A18582B4212Q34764884-C8D0C9F4-5D67-47A6-BD33-DB8B87E86A71Q34791129-0445E821-AAEB-4AFE-91C2-AC43A3ECB1A9Q35287715-EA9730C6-6710-48B1-BD71-DBFE263FA127Q35659602-5F7EB428-F908-4B34-99F4-20AA29C096C2Q35659606-6763090C-EAE6-4FEB-9E6C-5A7D791ECB64Q35683588-C4C7B36A-F5F7-4F84-8966-803B8D7D2C8CQ35852411-79F3B8F8-8DF2-45B8-86D7-2DB9A3498ACEQ35878943-991270D4-14BC-46F5-AB51-1B22306DCAE7Q35904795-4DD34524-15DC-4544-B090-DF3A9214F9F8Q36065535-E17B3077-24A9-4557-A654-12AA976FAECAQ36263849-426FD7F3-381E-4058-B7FF-2BAC6A4AF7A9Q36384976-40879F01-E266-4555-A3D1-98AA74FC6C84Q36385301-C89347AB-7C6A-42C1-BA92-FA65F7FE0105Q36393224-7AFB00DA-329C-478E-8BBF-157883BED40BQ36462833-E5B4B4EF-3375-459D-81EC-7A8F3DB6614CQ36491529-5A30233D-E2B0-49C9-97CF-B831A8A7A00CQ36625914-DBC92D3F-29B4-4176-A1CD-B0CEC314D203Q36638994-F6D9D94E-9063-4C71-BA2C-AFDC7A37C097
P2860
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Postmenopausal levels of oestr ...... results of a prospective study
@ast
Postmenopausal levels of oestr ...... results of a prospective study
@en
type
label
Postmenopausal levels of oestr ...... results of a prospective study
@ast
Postmenopausal levels of oestr ...... results of a prospective study
@en
prefLabel
Postmenopausal levels of oestr ...... results of a prospective study
@ast
Postmenopausal levels of oestr ...... results of a prospective study
@en
P2093
P2860
P50
P356
P1476
Postmenopausal levels of oestr ...... results of a prospective study
@en
P2093
A Akhmedkhanov
K L Koenig
Y Afanasyeva
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601517
P407
P577
2004-01-01T00:00:00Z